Hi, I am Pedro M. Garcia Barrantes. I am from Costa Rica. I received a Pharm. D. degree and a M. Sc. in Chemistry from the University of Costa Rica. I entered Vanderbilt through the Quantitative and Chemical Biology (QCB) Admissions program and I am interested in Medicinal Chemistry and Drug Discovery and Design.
After my arrival in the US, it has surprised me how nice people from Nashville are; even strangers stop to say hi. Also, the university facilities are outstanding with beautiful surroundings and lots of nature. I look forward to improving my skills in laboratory practice, making new friends and embracing the experience of graduate school at Vanderbilt and Nashville. At the end of my QCB year, I entered the lab of Dr. Craig Lindsley and the Chemical and Physical Biology graduate program.
Garcia-Barrantes PM, Cho HP, Blobaum AL, Niswender CM, Conn PJ, Lindsley CW. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core. Bioorganic and Medicinal Chemistry Letters (2015), Vol. 25(22), 5107-10.
Garcia-Barrantes PM, Cho HP, Niswender CM, Byers FW, Locuson CW, Blobaum AL, Xiang Z, Rook JM, Conn PJ, Lindsley CW. Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics. Journal of Medicinal Chemistry (2015), Vol. 58(20), 7959-71.
Conde-Ceide S, Martínez-Viturro CM, Alcázar J, Garcia-Barrantes PM, Lavreysen H, Mackie C, Vinson PN, Rook JM, Bridges TM, Daniels JS, Megens A, Langlois X, Drinkenburg WH, Ahnaou A, Niswender CM, Jones CK, Macdonald GJ, Steckler T, Conn PJ, Stauffer SR, Bartolomé-Nebreda JM, Lindsley CW. Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia. ACS Medicinal Chemistry Letters (2015), Vol. 6(6):716-20.
Hyekyung P. Cho, Pedro M. Garcia-Barrantes, John T. Brogan, Corey R. Hopkins, Colleen M. Niswender, Alice L. Rodriguez, Daryl F. Venable, Ryan D. Morrison, Michael Bubser, J. Scott Daniels, Carrie K. Jones, P. Jeffrey Conn, and Craig W. Lindsley. Chemical Modulation of Mutant mGlu1 Receptors Derived from Deleterious GRM1 Mutations Found in Schizophrenics. ACS Chemical Biology 2014 9 (10), 2334-2346. DOI: 10.1021/cb500560h.